Kelder A - Search Results

1

Prospective validation of the prognostic relevance of CD34+CD38- AML stem cell frequency in the HOVON-SAKK132 trial.

Ngai LL, Hanekamp D, Janssen F, Carbaat-Ham J, Hofland MAMA, Fayed MMHE, Kelder A, Oudshoorn-van Marsbergen L, Scholten WJ, Snel AN, Bachas C, Tettero JM, Breems DA, Fischer T, Gjertsen BT, Griškevičius L, Juliusson G, van de Loosdrecht AA, Maertens JA, Manz MG, Pabst T, Passweg JR, Porkka K, Valk PJM, Gradowska P, Löwenberg B, de Leeuw DC, Janssen JJWM, Ossenkoppele GJ, Cloos J. Ngai LL, et al. Among authors: kelder a. Blood. 2023 May 25;141(21):2657-2661. doi: 10.1182/blood.2022019160. Blood. 2023. PMID: 36898087 Free PMC article.

2

High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival.

van Rhenen A, Feller N, Kelder A, Westra AH, Rombouts E, Zweegman S, van der Pol MA, Waisfisz Q, Ossenkoppele GJ, Schuurhuis GJ. van Rhenen A, et al. Among authors: kelder a. Clin Cancer Res. 2005 Sep 15;11(18):6520-7. doi: 10.1158/1078-0432.CCR-05-0468. Clin Cancer Res. 2005. PMID: 16166428 Free article.

3

Aberrant marker expression patterns on the CD34+CD38- stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission.

van Rhenen A, Moshaver B, Kelder A, Feller N, Nieuwint AW, Zweegman S, Ossenkoppele GJ, Schuurhuis GJ. van Rhenen A, et al. Among authors: kelder a. Leukemia. 2007 Aug;21(8):1700-7. doi: 10.1038/sj.leu.2404754. Epub 2007 May 24. Leukemia. 2007. PMID: 17525725

4

The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells.

van Rhenen A, van Dongen GA, Kelder A, Rombouts EJ, Feller N, Moshaver B, Stigter-van Walsum M, Zweegman S, Ossenkoppele GJ, Jan Schuurhuis G. van Rhenen A, et al. Among authors: kelder a. Blood. 2007 Oct 1;110(7):2659-66. doi: 10.1182/blood-2007-03-083048. Epub 2007 Jul 3. Blood. 2007. PMID: 17609428 Free article.

5

Positive selection for CD90 as a purging option in acute myeloid leukemia stem cell transplants.

Feller N, Kelder A, Westra G, Ossenkoppele GJ, Schuurhuis GJ. Feller N, et al. Among authors: kelder a. Cytometry B Clin Cytom. 2008 Jan;74(1):9-16. doi: 10.1002/cyto.b.20375. Cytometry B Clin Cytom. 2008. PMID: 18061946 Free article.

6

Correlation of minimal residual disease cell frequency with molecular genotype in patients with acute myeloid leukemia.

Hess CJ, Feller N, Denkers F, Kelder A, Merle PA, Heinrich MC, Harlow A, Berkhof J, Ossenkoppele GJ, Waisfisz Q, Schuurhuis GJ. Hess CJ, et al. Among authors: kelder a. Haematologica. 2009 Jan;94(1):46-53. doi: 10.3324/haematol.13110. Epub 2008 Nov 27. Haematologica. 2009. PMID: 19042917 Free PMC article.

7

Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia.

Moshaver B, van Rhenen A, Kelder A, van der Pol M, Terwijn M, Bachas C, Westra AH, Ossenkoppele GJ, Zweegman S, Schuurhuis GJ. Moshaver B, et al. Among authors: kelder a. Stem Cells. 2008 Dec;26(12):3059-67. doi: 10.1634/stemcells.2007-0861. Stem Cells. 2008. PMID: 19096043

8

Interleukin-2 receptor alpha-chain (CD25) expression on leukaemic blasts is predictive for outcome and level of residual disease in AML.

Terwijn M, Feller N, van Rhenen A, Kelder A, Westra G, Zweegman S, Ossenkoppele G, Schuurhuis GJ. Terwijn M, et al. Among authors: kelder a. Eur J Cancer. 2009 Jun;45(9):1692-9. doi: 10.1016/j.ejca.2009.02.021. Epub 2009 Mar 25. Eur J Cancer. 2009. PMID: 19321337

9

Residual normal stem cells can be detected in newly diagnosed chronic myeloid leukemia patients by a new flow cytometric approach and predict for optimal response to imatinib.

Janssen JJ, Deenik W, Smolders KG, van Kuijk BJ, Pouwels W, Kelder A, Cornelissen JJ, Schuurhuis GJ, Ossenkoppele GJ. Janssen JJ, et al. Among authors: kelder a. Leukemia. 2012 May;26(5):977-84. doi: 10.1038/leu.2011.347. Epub 2011 Dec 9. Leukemia. 2012. PMID: 22157734

10

The role of minor subpopulations within the leukemic blast compartment of AML patients at initial diagnosis in the development of relapse.

Bachas C, Schuurhuis GJ, Assaraf YG, Kwidama ZJ, Kelder A, Wouters F, Snel AN, Kaspers GJ, Cloos J. Bachas C, et al. Among authors: kelder a. Leukemia. 2012 Jun;26(6):1313-20. doi: 10.1038/leu.2011.383. Epub 2012 Jan 13. Leukemia. 2012. PMID: 22289983

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

41 results

Search Page